Event and Time
Event Date: April to September 2020 Court Case: Medical Device Technologies Pty Ltd v Health Administration Corporation Judgement Date: September 2021
Event Description
In the context of the COVID-19 pandemic, Health Administration Corporation (HealthShare) entered into agreements with Medical Device Technologies Pty Ltd (MDT) for the purchase of 348 Shangrila 510S Integrated Respirator ventilators. Following delivery and subsequent testing, HealthShare contended that the ventilators were unfit for clinical use and initiated a legal claim seeking a refund of $10.395 million paid to MDT.
Application and Claims
MDT claimed the purchase price due under the agreements, while HealthShare argued for termination based on:
- Breach of HealthShare’s standard Purchase Order Terms and Conditions.
- Breach of implied conditions under the Sale of Goods Act (fit for purpose).
- Misleading or deceptive conduct as per Australian Consumer Law (ACL).
Judicial Decisions
- The court ruled that HealthShare was entitled to refund due to:
- Failure to establish incorporation of their Purchase Order Terms. - Ventilators being unfit for the intended clinical purpose. - Misleading or deceptive conduct from MDT regarding the ventilators’ specifications.
Dispute Points and Legal Basis
Dispute Points
- MDT's Claims:
- The ventilators were fit for purpose as per specifications provided. - HealthShare accepted the goods when payments were made. - Misleading statements were made regarding the 510 ventilators’ performance as representations.
- HealthShare's Arguments:
- Ventilators were unsuitable for clinical use based on testing results (inaccurate oxygen delivery, inadequate functionality). - HealthShare did not accept the goods as the expected performance was not met. - Misleading information was presented in the User Manual and promotional brochures.